Clinical Trials Browser

Phase 1/2 × Solid Tumor Cancer × 90 days × Clear all

NCT07441174 2026-02-27

IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid Tumors

Phase 1/2 Recruiting

GastrointestinalOther solid neoplasm

Solid Tumor Cancer